HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Use of trafermin to treat a skin ulcer after repair of a deep auricular laceration: a case report.

Abstract
We used trafermin (recombinant human basic fibroblast growth factor) to treat a skin ulcer (diameter, 1 cm; depth, 2 mm) that developed after an extremely deep auricular laceration was sutured. Excellent results were obtained after use of trafermin for 2 weeks. To our knowledge, we report the first clinical use of trafermin in a patient with a skin ulcer resulting from auricular trauma. Trafermin may promise to be an effective treatment for skin ulcers.
AuthorsTohru Tanigawa, Meiho Nakayama, Tomohiko Nakamura, Shigeru Inafuku
JournalThe Journal of dermatological treatment (J Dermatolog Treat) Vol. 16 Issue 5-6 Pg. 345-6 ( 2005) ISSN: 0954-6634 [Print] England
PMID16428158 (Publication Type: Case Reports, Journal Article)
Chemical References
  • Peptide Fragments
  • trafermin
  • Fibroblast Growth Factors
Topics
  • Aged
  • Ear, External (injuries)
  • Fibroblast Growth Factors (therapeutic use)
  • Humans
  • Lacerations (surgery)
  • Male
  • Peptide Fragments (therapeutic use)
  • Postoperative Complications
  • Skin Ulcer (drug therapy, etiology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: